Aurobindo Pharma to spend $200 million on Capex in FY20

Aurobindo Pharma to spend $200 million on Capex in FY20 The acquisition will add approximately 300 products, including projects under development, as well as commercial and manufacturing capabilities in the USA.

No comments:

Post a Comment